Biodexa Pharmaceuticals Plc ADR (BDRX)

Shares of Biodexa Pharmaceuticals Plc ADR (BDRX) dropped by 12.54% from $3.03 to $2.65 in the trading on Tuesday, December 19, 2023. The reason why BDRX down today is due to the announcement of a public offering of units, including Class A and Class B Units, each with various warrants and pricing. Ladenburg Thalmann & Co. Inc. is the sole book-running manager for the offering. The offering is expected to close on or about December 21, 2023. Market reaction to this announcement impacted BDRX's stock significantly.

Shares of Biodexa Pharmaceuticals Plc (BDRX) dropped by 11.57% from $4.15 to $3.67 in the trading on Wednesday, November 29, 2023. The reason why BDRX is down today is due to the company's announcement of a public offering. Biodexa Pharmaceuticals revealed its intention to offer 1,397,849 Class A units to the public. These units were assumed to be priced at $2.79 per Class A unit. The offering led to stock's dilution, which affected investors' earnings, contributing to the decline in BDRX's stock price.

Biodexa Pharmaceuticals Stock (BDRX) dropped by 18.79% from $5.11 to $4.15 in the trading on Tuesday November 28, 2023. The reason why BDRX stock down today is due to the announcement of a public offering. The company unveiled plans for a public offering of 1,397,849 Class A units at an assumed public offering price of $2.79 per Class A unit. The announcement of the public offering sent shockwaves through the market, causing BDRX going down sharply today.